Innovative Industrial Properties, Inc. Q3 FY2025 earnings call

• Completed $105 million initial investment into IQHQ, including $100 million into revolving credit facility and $5 million in preferred stock, with remaining $165 million in preferred stock to be funded by Q2 2027. - Secured a new $100 million secured revolving credit facility to support IQHQ investment. - Receivership proceedings for 4Front Ventures and Gold Flora ongoing; PharmaCann Illinois property expected to be regained by year-end, with efforts ongoing for other states; took back 4 California properties and evaluating options. - Q3 total revenues $64.7 million, adjusted funds from operations $48.3 million ($1.71 per share). Strong balance sheet with $2.7 billion in unencumbered gross assets, $80 million liquidity, and low leverage. Issued 246,000 shares of preferred stock for $5.9 million.

In the third quarter, the company completed an initial $105 million investment into IQHQ, a life science real estate platform. Total investment included $100 million into a revolving credit facility and $5 million in preferred stock. Remaining $165 million in preferred stock is expected to be funded by Q2 2027. For cannabis segment, total revenues were $64.7 million in Q3, with activities like receivership proceedings for 4Front Ventures and Gold Flora, progress in PharmaCann legal matters, and leasing activity. Life science segment saw a $100 million secured revolving credit facility closed to support IQHQ investment. Revenue contribution: Cannabis segment contributed the majority with $64.7 million, IQHQ investment is a new segment with growing potential.

• IQHQ investment expected to be highly accretive with blended interest rate exceeding 14%. - Evaluating capital structure and ongoing discussions regarding bonds maturing next year. - Expecting rent commencements from IQHQ and resolved legal matters to contribute to dividend, with timing dependent on receivership and legal processes.

• Legal uncertainties: Ongoing receivership proceedings for 4Front and Gold Flora, uncertainties in PharmaCann property recoveries in various states. - Cannabis industry risks: Dependence on federal rescheduling for industry growth, impact of black market on tenant credit and occupancy. - Life science risks: Potential risks associated with IQHQ investment, including competition and market conditions in the life science sector.

Q: Dividend timing and rent commencements A: Alan and Paul discussed timing of rent commencements from IQHQ, Gold Flora, and PharmaCann, with expectations of revenue from resolved legal matters in 6-9 months.

Q: Impact of rescheduling A: Alan and Paul discussed positive impact of rescheduling on tenant credit and growth, but also ongoing efforts in state-level combating of black market.

Q: Prioritization of opportunities A: Alan emphasized primary focus on cannabis industry, with life science as secondary but unique opportunity.

Q: ABR non-rent paying A: Alan stated roughly 20% of ABR is not rent paying, with small recent impacts from tenants.